尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记)
FITC-Linked Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR)
CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3
- 编号LAA141Hu81
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源抗体标记
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物荧光素
- 原抗体 -
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC; IF.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 796 ¥ 1856 ¥ 2652 ¥ 6630 ¥ 26520
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对uPAR的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别uPAR。
用法
免疫印迹：0.2-2µg/mL;1:250-2500
免疫组织化学：5-20µg/mL;1:25-100
免疫细胞化学：5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA141Hu01 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA141Hu02 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA141Hu04 | 尿激酶型纤溶酶原激活因子受体(uPAR)活性蛋白 | Cell culture; Activity Assays. |
| RPA141Hu04 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA141Hu03 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA141Hu04 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB |
| PAA141Hu01 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA141Hu02 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA141Hu03 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA141Hu71 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| LAA141Hu83 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAA141Hu81 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| FAA141Hu81 | 抗尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记) | FCM |
| MAA141Hu22 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA141Hu21 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB; IHC; ICC; IP. |
| LAA141Hu82 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| SEA141Hu | 尿激酶型纤溶酶原激活因子受体(uPAR)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA141Hu | 尿激酶型纤溶酶原激活因子受体(uPAR)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| International Journal of Cancer | Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice [Wiley: source] |
| Biomark Insights | Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism [PubMed: PMC3623607] |
| Biomarker insights | Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD) [PubMed: PMC3762604] |
| Am J Emerg Med | Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis [PubMed: 26615223] |
| Archives of Clinical Infectious Diseases | Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis [Archcid: 26346] |
| The American Journal of Emergency Medicine | Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis [science:S0735675715009559] |
| Journal of Clinical and Experimental Hepatology | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) … [10.1016:j.jceh.2018.02.001] |
| Turkish journal of trauma & emergency surgery | The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis [Pubmed: 31475329] |
| CELL TRANSPLANTATION | Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction [33787356] |
留言咨询